Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Exscientia AI Limited
Exscientia AI Limited
AstraZeneca
Imperial College London
Eisai Inc.
University of California, Irvine
Qurient Co., Ltd.
Duke University
Essen Biotech
Essen Biotech
New Phase Ltd.
DualityBio Inc.
Grey Wolf Therapeutics
University of Nebraska
Natera, Inc.
Second Life Therapeutics
Elephas
Elephas
RenJi Hospital
University Health Network, Toronto
Shanghai Junshi Bioscience Co., Ltd.
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
MacroGenics
Washington University School of Medicine
EtiraRx Australia Pty Ltd
Anhui Provincial Hospital
Washington University School of Medicine
Novita Pharmaceuticals, Inc.
University of California, Irvine
ModeX Therapeutics, An OPKO Health Company
Celldex Therapeutics
Tempus AI
University Hospital, Antwerp
Singlera Genomics Inc.
Universidade Federal de Pernambuco
Taproot Health
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
DxTerity Diagnostics
Xencor, Inc.
Second Affiliated Hospital of Guangzhou Medical University
Comprehensive Support Project for Oncology Research
Cancer Support Community, Research and Training Institute, Philadelphia
Beijing Friendship Hospital
Pfizer
Celldex Therapeutics
Zhejiang University
Fusion Pharmaceuticals Inc.
Children's Oncology Group
Massachusetts General Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital